• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

4.450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >
News headline image
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 21, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
April 30, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
April 21, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
April 20, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
March 18, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
March 17, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
February 03, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
January 12, 2026
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
December 16, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
October 30, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
September 08, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
August 08, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
May 22, 2025
From Bicycle Therapeutics
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 01, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
March 27, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
January 13, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 09, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2025
From Bicycle Therapeutics plc
Via Business Wire
News headline image
Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification
December 12, 2024
From Bicycle Therapeutics plc
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap